ID   GEPH_RAT                Reviewed;         768 AA.
AC   Q03555;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 3.
DT   02-OCT-2024, entry version 213.
DE   RecName: Full=Gephyrin;
DE   AltName: Full=Putative glycine receptor-tubulin linker protein;
DE   Includes:
DE     RecName: Full=Molybdopterin adenylyltransferase;
DE              Short=MPT adenylyltransferase;
DE              EC=2.7.7.75 {ECO:0000305|PubMed:9990024};
DE     AltName: Full=Domain G;
DE   Includes:
DE     RecName: Full=Molybdopterin molybdenumtransferase;
DE              Short=MPT Mo-transferase;
DE              EC=2.10.1.1 {ECO:0000305|PubMed:9990024};
DE     AltName: Full=Domain E;
GN   Name=Gphn; Synonyms=Gph;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=1319186; DOI=10.1016/0896-6273(92)90136-2;
RA   Prior P., Schmitt B., Grenningloh G., Pribilla I., Multhaup G.,
RA   Beyreuther K., Maulet Y., Werner P., Langosch D., Kirsch J., Betz H.;
RT   "Primary structure and alternative splice variants of gephyrin, a putative
RT   glycine receptor-tubulin linker protein.";
RL   Neuron 8:1161-1170(1992).
RN   [2]
RP   SEQUENCE REVISION TO 255.
RA   Schmitt B.;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), AND INTERACTION
RP   WITH GLRB.
RX   PubMed=11083919; DOI=10.1006/mcne.2000.0899;
RA   Meier J., De Chaldee M., Triller A., Vannier C.;
RT   "Functional heterogeneity of gephyrins.";
RL   Mol. Cell. Neurosci. 16:566-577(2000).
RN   [4]
RP   PARTIAL PROTEIN SEQUENCE, IDENTIFICATION BY MASS SPECTROMETRY, X-RAY
RP   CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 348-768 IN COMPLEX WITH GLRB, AND
RP   SUBUNIT.
RX   PubMed=15201864; DOI=10.1038/sj.emboj.7600256;
RA   Sola M., Bavro V.N., Timmins J., Franz T., Ricard-Blum S., Schoehn G.,
RA   Ruigrok R.W.H., Paarmann I., Saiyed T., O'Sullivan G.A., Schmitt B.,
RA   Betz H., Weissenhorn W.;
RT   "Structural basis of dynamic glycine receptor clustering by gephyrin.";
RL   EMBO J. 23:2510-2519(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=8264797; DOI=10.1038/366745a0;
RA   Kirsch J., Wolters I., Triller A., Betz H.;
RT   "Gephyrin antisense oligonucleotides prevent glycine receptor clustering in
RT   spinal neurons.";
RL   Nature 366:745-748(1993).
RN   [6]
RP   INTERACTION WITH GABARAP.
RX   PubMed=10900017; DOI=10.1073/pnas.97.15.8594;
RA   Kneussel M., Haverkamp S., Fuhrmann J.C., Wang H., Waessle H., Olsen R.W.,
RA   Betz H.;
RT   "The gamma-aminobutyric acid type A receptor (GABAAR)-associated protein
RT   GABARAP interacts with gephyrin but is not involved in receptor anchoring
RT   at the synapse.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8594-8599(2000).
RN   [7]
RP   FUNCTION, PATHWAY, AND CATALYTIC ACTIVITY.
RX   PubMed=9990024; DOI=10.1073/pnas.96.4.1333;
RA   Stallmeyer B., Schwarz G., Schulze J., Nerlich A., Reiss J., Kirsch J.,
RA   Mendel R.R.;
RT   "The neurotransmitter receptor-anchoring protein gephyrin reconstitutes
RT   molybdenum cofactor biosynthesis in bacteria, plants, and mammalian
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:1333-1338(1999).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12684523; DOI=10.1074/jbc.m301070200;
RA   Rees M.I., Harvey K., Ward H., White J.H., Evans L., Duguid I.C.,
RA   Hsu C.-C., Coleman S.L., Miller J., Baer K., Waldvogel H.J., Gibbon F.,
RA   Smart T.G., Owen M.J., Harvey R.J., Snell R.G.;
RT   "Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains
RT   to the glycine receptor, and mutation analysis in hyperekplexia.";
RL   J. Biol. Chem. 278:24688-24696(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201; SER-207 AND SER-283, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-201, AND SUBUNIT.
RX   PubMed=11325967; DOI=10.1074/jbc.m101923200;
RA   Sola M., Kneussel M., Heck I.S., Betz H., Weissenhorn W.;
RT   "X-ray crystal structure of the trimeric N-terminal domain of gephyrin.";
RL   J. Biol. Chem. 276:25294-25301(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 350-768 IN COMPLEX WITH GLRB,
RP   SUBCELLULAR LOCATION, INTERACTION WITH GLRB, AND MUTAGENESIS OF PHE-362;
RP   PRO-745 AND 745-PRO-PRO-746.
RX   PubMed=16511563; DOI=10.1038/sj.emboj.7601029;
RA   Kim E.Y., Schrader N., Smolinsky B., Bedet C., Vannier C., Schwarz G.,
RA   Schindelin H.;
RT   "Deciphering the structural framework of glycine receptor anchoring by
RT   gephyrin.";
RL   EMBO J. 25:1385-1395(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 350-768, INTERACTION WITH GLRB,
RP   AND SUBUNIT.
RX   PubMed=25137389; DOI=10.1021/cb500303a;
RA   Maric H.M., Kasaragod V.B., Schindelin H.;
RT   "Modulation of gephyrin-glycine receptor affinity by multivalency.";
RL   ACS Chem. Biol. 9:2554-2562(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 350-768 IN COMPLEX WITH GABRA3,
RP   INTERACTION WITH GABRA3 AND GLRB, AND SUBUNIT.
RX   PubMed=25531214; DOI=10.1038/ncomms6767;
RA   Maric H.M., Kasaragod V.B., Hausrat T.J., Kneussel M., Tretter V.,
RA   Stromgaard K., Schindelin H.;
RT   "Molecular basis of the alternative recruitment of GABA(A) versus glycine
RT   receptors through gephyrin.";
RL   Nat. Commun. 5:5767-5767(2014).
CC   -!- FUNCTION: Microtubule-associated protein involved in membrane protein-
CC       cytoskeleton interactions. It is thought to anchor the inhibitory
CC       glycine receptor (GLYR) to subsynaptic microtubules (PubMed:8264797).
CC       Acts as a major instructive molecule at inhibitory synapses, where it
CC       also clusters GABA type A receptors (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BUV3, ECO:0000269|PubMed:8264797}.
CC   -!- FUNCTION: Has also a catalytic activity and catalyzes two steps in the
CC       biosynthesis of the molybdenum cofactor. In the first step,
CC       molybdopterin is adenylated. Subsequently, molybdate is inserted into
CC       adenylated molybdopterin and AMP is released.
CC       {ECO:0000269|PubMed:9990024}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H(+) + molybdopterin = adenylyl-molybdopterin +
CC         diphosphate; Xref=Rhea:RHEA:31331, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58698,
CC         ChEBI:CHEBI:62727; EC=2.7.7.75;
CC         Evidence={ECO:0000305|PubMed:9990024};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31332;
CC         Evidence={ECO:0000305|PubMed:9990024};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenylyl-molybdopterin + molybdate = AMP + H(+) + Mo-
CC         molybdopterin; Xref=Rhea:RHEA:35047, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:36264, ChEBI:CHEBI:62727, ChEBI:CHEBI:71302,
CC         ChEBI:CHEBI:456215; EC=2.10.1.1;
CC         Evidence={ECO:0000305|PubMed:9990024};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35048;
CC         Evidence={ECO:0000305|PubMed:9990024};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Inhibited by copper and tungsten. {ECO:0000250}.
CC   -!- PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.
CC       {ECO:0000305|PubMed:9990024}.
CC   -!- SUBUNIT: Homotrimer, homodimer and homooligomer (PubMed:11325967,
CC       PubMed:25137389, PubMed:25531214). Interacts with SRGAP2 (via SH3
CC       domain) (By similarity). Interacts with GLRB (PubMed:15201864,
CC       PubMed:16511563, PubMed:25137389, PubMed:25531214). Interacts with
CC       GABARAP (PubMed:10900017). Interacts with GABRA3 (PubMed:25531214).
CC       GABRA3 and GLRB occupy overlapping binding sites (PubMed:25531214).
CC       Interacts with ARHGAP32; IQSEC3, INSYN1 and INSYN2A (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BUV3, ECO:0000269|PubMed:10900017,
CC       ECO:0000269|PubMed:11325967, ECO:0000269|PubMed:15201864,
CC       ECO:0000269|PubMed:16511563}.
CC   -!- INTERACTION:
CC       Q03555; P48168: Glrb; Xeno; NbExp=4; IntAct=EBI-349317, EBI-7069198;
CC       Q03555-6; P20236: Gabra3; NbExp=5; IntAct=EBI-5273276, EBI-5273284;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:16511563}; Lipid-anchor
CC       {ECO:0000305|PubMed:16511563}; Cytoplasmic side
CC       {ECO:0000269|PubMed:16511563}. Cell membrane
CC       {ECO:0000269|PubMed:12684523}; Lipid-anchor
CC       {ECO:0000305|PubMed:12684523}; Cytoplasmic side
CC       {ECO:0000305|PubMed:12684523}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q9NQX3}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:16511563}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q9NQX3}. Postsynaptic density
CC       {ECO:0000250|UniProtKB:Q8BUV3}. Note=Cytoplasmic face of glycinergic
CC       postsynaptic membranes (PubMed:16511563). Forms clusters at synapses
CC       (By similarity). {ECO:0000250|UniProtKB:Q8BUV3,
CC       ECO:0000269|PubMed:16511563}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=6;
CC         IsoId=Q03555-1; Sequence=Displayed;
CC       Name=1; Synonyms=GE124'56;
CC         IsoId=Q03555-2; Sequence=VSP_003238;
CC       Name=2; Synonyms=GE236;
CC         IsoId=Q03555-3; Sequence=VSP_003239, VSP_003240, VSP_003243;
CC       Name=3; Synonyms=GE24'6;
CC         IsoId=Q03555-4; Sequence=VSP_003239;
CC       Name=4; Synonyms=GE245;
CC         IsoId=Q03555-5; Sequence=VSP_003241, VSP_003242;
CC       Name=5; Synonyms=GE26;
CC         IsoId=Q03555-6; Sequence=VSP_003239, VSP_003243;
CC   -!- TISSUE SPECIFICITY: Expressed in tissues including spinal cord, brain,
CC       liver, kidney and lung.
CC   -!- PTM: Phosphorylated.
CC   -!- PTM: Palmitoylated. Palmitoylation is stimulated by GABA type A
CC       receptors activity. Palmitoylation by ZDHHC12 regulates clustering at
CC       synapses. {ECO:0000250|UniProtKB:Q8BUV3}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the MoaB/Mog family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the MoeA family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X66366; CAA47009.2; -; mRNA.
DR   PIR; JH0681; JH0681.
DR   RefSeq; NP_074056.2; NM_022865.3. [Q03555-6]
DR   PDB; 1IHC; X-ray; 1.90 A; A=1-201.
DR   PDB; 1T3E; X-ray; 3.25 A; A/B=348-768.
DR   PDB; 2FTS; X-ray; 2.41 A; A=350-768.
DR   PDB; 2FU3; X-ray; 2.70 A; A/B=350-768.
DR   PDB; 4PD0; X-ray; 1.70 A; A=350-768.
DR   PDB; 4PD1; X-ray; 1.98 A; A=350-768.
DR   PDB; 4TK1; X-ray; 2.70 A; A/B=350-768.
DR   PDB; 4TK2; X-ray; 4.10 A; A/B=350-768.
DR   PDB; 4TK3; X-ray; 2.70 A; A/B=350-768.
DR   PDB; 4TK4; X-ray; 3.60 A; A/B=350-768.
DR   PDB; 4U90; X-ray; 2.00 A; A=350-768.
DR   PDB; 4U91; X-ray; 2.00 A; A=350-768.
DR   PDB; 5ERQ; X-ray; 1.55 A; A=350-768.
DR   PDB; 5ERR; X-ray; 1.65 A; A=350-768.
DR   PDB; 5ERS; X-ray; 1.70 A; A=350-768.
DR   PDB; 5ERT; X-ray; 2.00 A; A=350-768.
DR   PDB; 5ERU; X-ray; 1.60 A; A=350-768.
DR   PDB; 5ERV; X-ray; 1.80 A; A=350-768.
DR   PDB; 6FGC; X-ray; 1.50 A; A=350-768.
DR   PDB; 6FGD; X-ray; 1.50 A; A=350-768.
DR   PDB; 6HSN; X-ray; 1.55 A; A=350-768.
DR   PDB; 6HSO; X-ray; 1.95 A; A=350-768.
DR   PDBsum; 1IHC; -.
DR   PDBsum; 1T3E; -.
DR   PDBsum; 2FTS; -.
DR   PDBsum; 2FU3; -.
DR   PDBsum; 4PD0; -.
DR   PDBsum; 4PD1; -.
DR   PDBsum; 4TK1; -.
DR   PDBsum; 4TK2; -.
DR   PDBsum; 4TK3; -.
DR   PDBsum; 4TK4; -.
DR   PDBsum; 4U90; -.
DR   PDBsum; 4U91; -.
DR   PDBsum; 5ERQ; -.
DR   PDBsum; 5ERR; -.
DR   PDBsum; 5ERS; -.
DR   PDBsum; 5ERT; -.
DR   PDBsum; 5ERU; -.
DR   PDBsum; 5ERV; -.
DR   PDBsum; 6FGC; -.
DR   PDBsum; 6FGD; -.
DR   PDBsum; 6HSN; -.
DR   PDBsum; 6HSO; -.
DR   AlphaFoldDB; Q03555; -.
DR   SMR; Q03555; -.
DR   BioGRID; 249211; 10.
DR   DIP; DIP-33263N; -.
DR   IntAct; Q03555; 9.
DR   MINT; Q03555; -.
DR   STRING; 10116.ENSRNOP00000064099; -.
DR   iPTMnet; Q03555; -.
DR   PhosphoSitePlus; Q03555; -.
DR   SwissPalm; Q03555; -.
DR   jPOST; Q03555; -.
DR   PaxDb; 10116-ENSRNOP00000064099; -.
DR   ABCD; Q03555; 3 sequenced antibodies.
DR   Ensembl; ENSRNOT00000100642.1; ENSRNOP00000091082.1; ENSRNOG00000064046.1. [Q03555-1]
DR   Ensembl; ENSRNOT00000101616.1; ENSRNOP00000083857.1; ENSRNOG00000064630.1. [Q03555-3]
DR   Ensembl; ENSRNOT00000104959.1; ENSRNOP00000097129.1; ENSRNOG00000064630.1. [Q03555-5]
DR   Ensembl; ENSRNOT00000106781.1; ENSRNOP00000082928.1; ENSRNOG00000064046.1. [Q03555-5]
DR   Ensembl; ENSRNOT00000107245.1; ENSRNOP00000082164.1; ENSRNOG00000064630.1. [Q03555-1]
DR   Ensembl; ENSRNOT00000108357.1; ENSRNOP00000093484.1; ENSRNOG00000064046.1. [Q03555-3]
DR   Ensembl; ENSRNOT00055031339; ENSRNOP00055025296; ENSRNOG00055018422. [Q03555-1]
DR   Ensembl; ENSRNOT00055031637; ENSRNOP00055025568; ENSRNOG00055018485. [Q03555-1]
DR   Ensembl; ENSRNOT00060045979; ENSRNOP00060038170; ENSRNOG00060026299. [Q03555-1]
DR   Ensembl; ENSRNOT00060047961; ENSRNOP00060039905; ENSRNOG00060027041. [Q03555-1]
DR   Ensembl; ENSRNOT00065030170; ENSRNOP00065023971; ENSRNOG00065017865. [Q03555-1]
DR   GeneID; 64845; -.
DR   KEGG; rno:64845; -.
DR   UCSC; RGD:69194; rat. [Q03555-1]
DR   AGR; RGD:69194; -.
DR   CTD; 10243; -.
DR   RGD; 69194; Gphn.
DR   eggNOG; KOG2371; Eukaryota.
DR   GeneTree; ENSGT00390000016577; -.
DR   InParanoid; Q03555; -.
DR   OrthoDB; 275356at2759; -.
DR   PhylomeDB; Q03555; -.
DR   Reactome; R-RNO-947581; Molybdenum cofactor biosynthesis.
DR   UniPathway; UPA00344; -.
DR   EvolutionaryTrace; Q03555; -.
DR   PRO; PR:Q03555; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:RGD.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0099572; C:postsynaptic specialization; IDA:SynGO.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IEA:GOC.
DR   GO; GO:0099091; C:postsynaptic specialization, intracellular component; IDA:SynGO.
DR   GO; GO:0097060; C:synaptic membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:RGD.
DR   GO; GO:0061598; F:molybdopterin adenylyltransferase activity; IDA:MGI.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISO:RGD.
DR   GO; GO:0061599; F:molybdopterin molybdotransferase activity; IDA:MGI.
DR   GO; GO:0008940; F:nitrate reductase activity; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; TAS:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0015631; F:tubulin binding; TAS:RGD.
DR   GO; GO:0045184; P:establishment of protein localization; IMP:BHF-UCL.
DR   GO; GO:0007529; P:establishment of synaptic specificity at neuromuscular junction; ISO:RGD.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; ISS:UniProtKB.
DR   GO; GO:0072579; P:glycine receptor clustering; ISO:RGD.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:MGI.
DR   GO; GO:0032324; P:molybdopterin cofactor biosynthetic process; ISO:RGD.
DR   GO; GO:0099645; P:neurotransmitter receptor localization to postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0098970; P:postsynaptic neurotransmitter receptor diffusion trapping; ISO:RGD.
DR   GO; GO:0006605; P:protein targeting; TAS:RGD.
DR   GO; GO:0010038; P:response to metal ion; ISO:RGD.
DR   GO; GO:0007416; P:synapse assembly; IEP:RGD.
DR   CDD; cd00887; MoeA; 1.
DR   CDD; cd00886; MogA_MoaB; 1.
DR   Gene3D; 3.40.980.10; MoaB/Mog-like domain; 2.
DR   Gene3D; 2.40.340.10; MoeA, C-terminal, domain IV; 1.
DR   Gene3D; 3.90.105.10; Molybdopterin biosynthesis moea protein, domain 2; 1.
DR   Gene3D; 2.170.190.11; Molybdopterin biosynthesis moea protein, domain 3; 1.
DR   InterPro; IPR036425; MoaB/Mog-like_dom_sf.
DR   InterPro; IPR001453; MoaB/Mog_dom.
DR   InterPro; IPR008284; MoCF_biosynth_CS.
DR   InterPro; IPR038987; MoeA-like.
DR   InterPro; IPR005111; MoeA_C_domain_IV.
DR   InterPro; IPR036688; MoeA_C_domain_IV_sf.
DR   InterPro; IPR005110; MoeA_linker/N.
DR   InterPro; IPR036135; MoeA_linker/N_sf.
DR   NCBIfam; NF045515; Glp_gephyrin; 1.
DR   NCBIfam; TIGR00177; molyb_syn; 2.
DR   PANTHER; PTHR10192:SF5; GEPHYRIN; 1.
DR   PANTHER; PTHR10192; MOLYBDOPTERIN BIOSYNTHESIS PROTEIN; 1.
DR   Pfam; PF00994; MoCF_biosynth; 2.
DR   Pfam; PF03454; MoeA_C; 1.
DR   Pfam; PF03453; MoeA_N; 1.
DR   SMART; SM00852; MoCF_biosynth; 2.
DR   SUPFAM; SSF63867; MoeA C-terminal domain-like; 1.
DR   SUPFAM; SSF63882; MoeA N-terminal region -like; 1.
DR   SUPFAM; SSF53218; Molybdenum cofactor biosynthesis proteins; 2.
DR   PROSITE; PS01078; MOCF_BIOSYNTHESIS_1; 1.
DR   PROSITE; PS01079; MOCF_BIOSYNTHESIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Cell projection; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Molybdenum;
KW   Molybdenum cofactor biosynthesis; Multifunctional enzyme;
KW   Nucleotide-binding; Palmitate; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Synapse; Transferase.
FT   CHAIN           1..768
FT                   /note="Gephyrin"
FT                   /id="PRO_0000170965"
FT   REGION          14..166
FT                   /note="MPT Mo-transferase"
FT   REGION          153..348
FT                   /note="Interaction with GABARAP"
FT                   /evidence="ECO:0000269|PubMed:10900017"
FT   REGION          194..245
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..316
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          326..768
FT                   /note="MPT adenylyltransferase"
FT   COMPBIAS        219..238
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        273..300
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQX3"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         278
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         279
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQX3"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQX3"
FT   LIPID           225
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQX3"
FT   LIPID           297
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQX3"
FT   VAR_SEQ         1..22
FT                   /note="MATEGMILTNHDHQIRVGVLTV -> MSFPLSPAFTLLHILV (in
FT                   isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:11083919"
FT                   /id="VSP_003238"
FT   VAR_SEQ         99..111
FT                   /note="Missing (in isoform 5, isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11083919,
FT                   ECO:0000303|PubMed:1319186"
FT                   /id="VSP_003239"
FT   VAR_SEQ         256
FT                   /note="K -> KNHPFYTSPAVFMANHGQPIPGLISYSHHATGSADKR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11083919"
FT                   /id="VSP_003240"
FT   VAR_SEQ         302..320
FT                   /note="Missing (in isoform 5 and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11083919,
FT                   ECO:0000303|PubMed:1319186"
FT                   /id="VSP_003243"
FT   VAR_SEQ         302..315
FT                   /note="QIRRPDESKGVASR -> ARLPSCSSTYSVSE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11083919"
FT                   /id="VSP_003241"
FT   VAR_SEQ         316..320
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11083919"
FT                   /id="VSP_003242"
FT   MUTAGEN         362
FT                   /note="F->A: Reduced GLRB binding."
FT                   /evidence="ECO:0000269|PubMed:16511563"
FT   MUTAGEN         745..746
FT                   /note="PP->AA: Reduced GLRB binding."
FT                   /evidence="ECO:0000269|PubMed:16511563"
FT   MUTAGEN         745
FT                   /note="P->A: Loss of GLRB binding."
FT                   /evidence="ECO:0000269|PubMed:16511563"
FT   CONFLICT        255
FT                   /note="A -> R (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   STRAND          16..22
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           24..27
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           34..44
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   TURN            46..49
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          52..59
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           63..75
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          80..86
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           112..116
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           122..135
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           137..141
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          146..149
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          152..157
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           161..171
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           175..182
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   HELIX           188..193
FT                   /evidence="ECO:0007829|PDB:1IHC"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:6HSN"
FT   HELIX           358..368
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          374..378
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           379..381
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          386..389
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          397..400
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          402..410
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           412..414
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          416..425
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          439..443
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          455..458
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           459..461
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          462..467
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          471..479
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   TURN            485..488
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          494..496
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          501..503
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           511..520
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          524..528
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          533..538
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           558..568
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          573..579
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           583..596
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          598..604
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          607..609
FT                   /evidence="ECO:0007829|PDB:5ERQ"
FT   TURN            610..613
FT                   /evidence="ECO:0007829|PDB:5ERQ"
FT   HELIX           614..620
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          625..632
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          640..646
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          649..656
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   HELIX           660..678
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          688..695
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          704..711
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          716..718
FT                   /evidence="ECO:0007829|PDB:1T3E"
FT   STRAND          720..723
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          728..730
FT                   /evidence="ECO:0007829|PDB:2FTS"
FT   HELIX           733..735
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          740..744
FT                   /evidence="ECO:0007829|PDB:6FGC"
FT   STRAND          752..754
FT                   /evidence="ECO:0007829|PDB:6HSN"
FT   STRAND          759..764
FT                   /evidence="ECO:0007829|PDB:6FGC"
SQ   SEQUENCE   768 AA;  83266 MW;  FAD1B6DD76ED79EA CRC64;
     MATEGMILTN HDHQIRVGVL TVSDSCFRNL AEDRSGINLK DLVQDPSLLG GTISAYKIVP
     DEIEEIKETL IDWCDEKELN LILTTGGTGF APRDVTPEKF PTFPFCGLQK GATKEVIERE
     APGMALAMLM GSLNVTPLGM LSRPVCGIRG KTLIINLPGS KKGSQECFQF ILPALPHAID
     LLRDAIVKVK EVHDELEDLP SPPPPLSPPP TTSPHKQTED KGVQCEEEEE EKKDSGVAST
     EDSSSSHITA AALAAKIPDS IISRGVQVLP RDTASLSTTP SESPRAQATS RLSTASCPTP
     KQIRRPDESK GVASRVGSLK VQSRCSSKEN ILRASHSAVD ITKVARRHRM SPFPLTSMDK
     AFITVLEMTP VLGTEIINYR DGMGRVLAQD VYAKDNLPPF PASVKDGYAV RAADGPGDRF
     IIGESQAGEQ PTQTVMPGQV MRVTTGAPIP CGADAVVQVE DTELIRESDD GTEELEVRIL
     VQARPGQDIR PIGHDIKRGE CVLAKGTHMG PSEIGLLATV GVTEVEVNKF PVVAVMSTGN
     ELLNPEDDLL PGKIRDSNRS TLLATIQEHG YPTINLGIVG DNPDDLLNAL NEGISRADVI
     ITSGGVSMGE KDYLKQVLDI DLHAQIHFGR VFMKPGLPTT FATLDIDGVR KIIFALPGNP
     VSAVVTCNLF VVPALRKMQG ILDPRPTIIK ARLSCDVKLD PRPEYHRCIL TWHHQEPLPW
     AQSTGNQMSS RLMSMRSANG LLMLPPKTEQ YVELHKGEVV DVMVIGRL
//
